Expert Review of Hematology, Volume 13, Issue 11 (2020)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Expert Review of Hematology, Volume 13, Issue 11 (2020)

See all volumes and issues
Vol 17, 2024 Vol 16, 2023 Vol 15, 2022 Vol 14, 2021 Volume 13, 2020 Vol 12, 2019 Vol 11, 2018 Vol 10, 2017 Vol 9, 2016 Vol 8, 2015 Vol 7, 2014 Vol 6, 2013 Vol 5, 2012 Vol 4, 2011 Vol 3, 2010 Vol 2, 2009 Vol 1, 2008
Download citations Download PDFs Download issue

Drug Profile

Article
A critical evaluation of caplacizumab for the treatment of acquired thrombotic thrombocytopenic purpura
Inés Gómez-Seguí, Miguel Fernández-Zarzoso & Javier de la Rubia
Pages: 1153-1164
Published online: 12 Oct 2020
AbstractforA critical evaluation of caplacizumab for the treatment of acquired thrombotic thrombocytopenic purpura | Full Text | References | PDF (1.6 MB) | EPUB
  • 463 Views
  • 8 CrossRef citations
  • 0Altmetric

Perspective

What is the future of patient-reported outcomes in sickle-cell disease?
Sharon A. Singh, Nitya Bakshi, Prashant Mahajan & Claudia R. Morris
Pages: 1165-1173
Published online: 15 Oct 2020
AbstractforWhat is the future of patient-reported outcomes in sickle-cell disease? | Full Text | References | PDF (362.6 KB) | EPUB
  • 363 Views
  • 10 CrossRef citations
  • 0Altmetric
Revisiting the treatment of anemia in the setting of chronic kidney disease, hematologic malignancies, and cancer: perspectives with opinion and commentary
Franco Musio
Pages: 1175-1188
Published online: 02 Nov 2020
AbstractforRevisiting the treatment of anemia in the setting of chronic kidney disease, hematologic malignancies, and cancer: perspectives with opinion and commentary | Full Text | References | PDF (375.2 KB) | EPUB
  • 413 Views
  • 2 CrossRef citations
  • 0Altmetric

Review

Novel and combination therapies for polycythemia vera and essential thrombocythemia: the dawn of a new era
Jan Philipp Bewersdorf & Amer M. Zeidan
Pages: 1189-1199
Published online: 01 Nov 2020
AbstractforNovel and combination therapies for polycythemia vera and essential thrombocythemia: the dawn of a new era | Full Text | References | PDF (1.3 MB) | EPUB
  • 317 Views
  • 0 CrossRef citations
  • 0Altmetric
Glucose-regulated protein 78 (GRP78) as a potential novel biomarker and therapeutic target in multiple myeloma
Slavisa Ninkovic, Simon J. Harrison & Hang Quach
Pages: 1201-1210
Published online: 18 Oct 2020
AbstractforGlucose-regulated protein 78 (GRP78) as a potential novel biomarker and therapeutic target in multiple myeloma | Full Text | References | PDF (4.7 MB) | EPUB
  • 570 Views
  • 11 CrossRef citations
  • 0Altmetric
Bispecific antibodies in acute lymphoblastic leukemia therapy
Guranda Chitadze, Anna Laqua, Marcus Lettau, Claudia D Baldus & Monika Brüggemann
Pages: 1211-1233
Published online: 04 Nov 2020
AbstractforBispecific antibodies in acute lymphoblastic leukemia therapy | Full Text | References | PDF (4.1 MB) | EPUB
  • 320 Views
  • 4 CrossRef citations
  • 0Altmetric
Reducing infectious complications after allogeneic stem cell transplant
Andrea Bacigalupo, Elisabetta Metafuni, Viviana Amato, Ester Marquez Algaba & Livio Pagano
Pages: 1235-1251
Published online: 03 Nov 2020
AbstractforReducing infectious complications after allogeneic stem cell transplant | Full Text | References | PDF (503.4 KB) | EPUB
  • 315 Views
  • 4 CrossRef citations
  • 0Altmetric
Developing strategies to reduce the duration of therapy for patients with myeloproliferative neoplasms
Michal Bar-Natan & Ronald Hoffman
Pages: 1253-1264
Published online: 19 Oct 2020
AbstractforDeveloping strategies to reduce the duration of therapy for patients with myeloproliferative neoplasms | Full Text | References | PDF (378.2 KB) | EPUB
  • 114 Views
  • 0 CrossRef citations
  • 0Altmetric
D-dimer level in COVID-19 infection: a systematic review
Mehrdad Rostami & Hassan Mansouritorghabeh
Pages: 1265-1275
Published online: 12 Oct 2020
AbstractforD-dimer level in COVID-19 infection: a systematic review | Full Text | References | PDF (295 KB) | EPUB
  • 30188 Views
  • 192 CrossRef citations
  • 0Altmetric

Original Research

Article
Copy-number variations in adult patients with chronic immune thrombocytopenia
Emrah Yucesan, Ozden Hatirnaz Ng, Fevzi Firat Yalniz, Hulya Yilmaz, Ayse Salihoglu, Tugce Sudutan, Ahmet Emre Eskazan, Seniz Ongoren, Zafer Baslar, Teoman Soysal, Ugur Ozbek, Muge Sayitoglu & M. Cem Ar
Pages: 1277-1287
Published online: 23 Sep 2020
AbstractforCopy-number variations in adult patients with chronic immune thrombocytopenia | Full Text | References | PDF (3.3 MB) | EPUB | Supplemental
  • 142 Views
  • 2 CrossRef citations
  • 0Altmetric
Article
Co-existence of mutations in myeloproliferative neoplasms and their clinical significance: a prognostic approach
Elham Homaei Hadad, Seyed Mohammad Sadegh Pezeshki, Saeid Shahrabi, Amal Saki Malehi & Najmaldin Saki
Pages: 1289-1301
Published online: 29 Sep 2020
AbstractforCo-existence of mutations in myeloproliferative neoplasms and their clinical significance: a prognostic approach | Full Text | References | PDF (412.2 KB) | EPUB
  • 117 Views
  • 2 CrossRef citations
  • 0Altmetric

Explore articles

Explore the most recently published articles

Clinical presentation and management of atypical hemolytic uremic syndrome in Latin America: a narrative review of the literature
Ra. Sepúlveda Palamara et al.
Review Article | Published online: 6 Jun 2024
Early diagnosis of persons with von Willebrand disease using a machine learning algorithm and real-world data
Robert F. Sidonio Jr et al.
Article | Published online: 24 May 2024
Open Access
Evaluating zanubrutinib for the treatment of adults with chronic lymphocytic leukemia or small lymphocytic lymphoma
Nathalie Javidi-Sharifi et al.
Review Article | Published online: 24 May 2024
Olutasidenib: a novel mutant IDH1 inhibitor for the treatment of relapsed or refractory acute myeloid leukemia
Jorge E. Cortes
Review Article | Published online: 21 May 2024
Open Access
View all latest articles